Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Even after more than 50 MMPl-icenses we still have the same share price trouble

Also, the market remembers the last 10Q in which a company paid $250K for a license. License signings will no longer cause any blips in the SP unless the 10Qs start showing some meaningful revenue from license signings.

Share
New Message
Please login to post a reply